Ingliforib

This classification denotes an anti-diabetic agent with the molecular formula C23H24ClN3O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) UII7156WLU, chemically known as 1h-indole-2-carboxamide, 5-chloro-n-((1s,2r)-3-((3r,4s)-3,4-dihydroxy-1-pyrrolidinyl)-2-hydroxy-3-oxo-1-(phenylmethyl)propyl)- but more generally known as ingliforib, which bears US NIH Compound Identifier 6451325. The term INGLIFORIB is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16., No. 1.2002, List 47). Most nations, for tariff and trade purposes, schedule ingliforib under HS 29339990 and SITC 51577. As of Q4 2014, INGLIFORIB remains US FDA's Preferred Term for this commodity. Ingliforib bears US NLM identifiers UMLS ID C1436456 and NCI Concept Code C75982. SMILES: C1C(C(CN1C(=O)C(C(CC2=CC=CC=C2)NC(=O)C3=CC4=C(N3)C=CC(=C4)CL)O)O)O.